C03CA01 - Furosemide |
Propably not porphyrinogenic |
PNP |
Rationale
(CAVE: under revision)Sulfonamide derivative. Conflicting references, but non-metabolism as well as clinical observations point to non-porphyrinogenicity.
Chemical description
Sulfonamide derivative.
Therapeutic characteristics
Shortacting loop-diuretic.
Metabolism and pharmacokinetics
Primarily excreted by filtration and secretion as unchanged drug. Some liver metabolism may occur. The glucuronide is the most significant metabolite. Non-porphyrinogenic metabolism.
Personal communication
Thunell, patient report (n=2): tolerated. Andersson, patient report (n=9): tolerated.
Published experience
Two non-English publications seem to involve uneventful exposure of two acute porphyria patients (Lopes Montes 2004, Moeschlin 1975).
IPNet drug reports
Uneventful use reported in 47 patients with acute porphyria.
References
- Scientific articles
- Moeschlin S, 1975. PMID 56031. PMID 56031. #4397
- Lopes Montes A et al. 2004. PMID 15219077. PMID 15219077. #4396
Similar drugs
© NAPOS 2024